Indication
Rezim is indicated for noncirrhotic Non-alcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (scarring).
Dosage and Administration
| Indication | Patient Category | Recommended dose |
| Rezim (Resmetirom INN 80 mg & 100 mg Tablet) | Adults (18 years or older) in conjunction with diet and exercise for the treatment of Fatty liver-NASH & Fibrosis | Once daily |
OR, AS DIRECTED BY PHYSICIAN.
Composition
Rezim 80 mg Tablet: Each tablet contains Resmetirom INN 80 mg.
Rezim 100 mg Tablet: Each tablet contains Resmetirom INN 100 mg.